Concepedia

Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial

Alexander P. J. Vlaar, Sanne de Bruin, Matthias H. Busch, Sjoerd A.M.E.G. Timmermans, Ingeborg E. van Zeggeren, Rutger Koning, Liora ter Horst, Esther Bulle, Frank E.H.P. van Baarle, Marcel C.G. van de Poll,

The Lancet Rheumatology · 2020 · 200 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Clinical Characteristics of Coronavirus Disease 2019 in China

Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text

, , +10

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet · 2020 · 29.1K citations · Full text

, , +12

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Chaomin Wu, Yanping Cai, Jiaan Xia et al. · JAMA Internal Medicine · 2020 · 8.7K citations · Full text

, , +17

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

Giacomo Grasselli, Alberto Zangrillo, Alberto Zanella et al. · JAMA · 2020 · 5.9K citations · Full text

, , +14

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann, Stijn E. Verleden, Mark Kuehnel et al. · New England Journal of Medicine · 2020 · 5.9K citations · Full text

, , +17